- Home
- ALMU vs BWAY Comparison
ALMU vs BWAY Comparison
Compare ALMU & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMU
- BWAY
- Stock Information
- Founded
- ALMU 2019
- BWAY 2003
- Country
- ALMU United States
- BWAY Israel
- Employees
- ALMU N/A
- BWAY N/A
- Industry
- ALMU Semiconductors
- BWAY Medical/Dental Instruments
- Sector
- ALMU Technology
- BWAY Health Care
- Exchange
- ALMU Nasdaq
- BWAY Nasdaq
- Market Cap
- ALMU 314.8M
- BWAY 280.7M
- IPO Year
- ALMU N/A
- BWAY 2019
- Fundamental
- Price
- ALMU $17.58
- BWAY $15.53
- Analyst Decision
- ALMU Strong Buy
- BWAY Strong Buy
- Analyst Count
- ALMU 2
- BWAY 2
- Target Price
- ALMU $25.50
- BWAY $18.00
- AVG Volume (30 Days)
- ALMU 470.3K
- BWAY 60.5K
- Earning Date
- ALMU 11-07-2025
- BWAY 11-11-2025
- Dividend Yield
- ALMU N/A
- BWAY N/A
- EPS Growth
- ALMU N/A
- BWAY 679.98
- EPS
- ALMU N/A
- BWAY 0.11
- Revenue
- ALMU $4,665,000.00
- BWAY $46,084,000.00
- Revenue This Year
- ALMU $19.59
- BWAY $335.63
- Revenue Next Year
- ALMU $98.73
- BWAY $22.10
- P/E Ratio
- ALMU N/A
- BWAY $55.04
- Revenue Growth
- ALMU 407.62
- BWAY 26.50
- 52 Week Low
- ALMU $2.52
- BWAY $7.84
- 52 Week High
- ALMU $25.88
- BWAY $17.00
- Technical
- Relative Strength Index (RSI)
- ALMU 48.88
- BWAY 50.21
- Support Level
- ALMU $17.03
- BWAY $14.68
- Resistance Level
- ALMU $19.28
- BWAY $16.28
- Average True Range (ATR)
- ALMU 1.74
- BWAY 0.63
- MACD
- ALMU 0.10
- BWAY -0.09
- Stochastic Oscillator
- ALMU 36.34
- BWAY 40.72
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.